219 related articles for article (PubMed ID: 19811284)
1. Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis.
Urbonaviciute V; Meister S; Fürnrohr BG; Frey B; Gückel E; Schett G; Herrmann M; Voll RE
Autoimmunity; 2009 May; 42(4):305-7. PubMed ID: 19811284
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.
Abdulahad DA; Westra J; Limburg PC; Kallenberg CG; Bijl M
Autoimmun Rev; 2010 Aug; 9(10):661-5. PubMed ID: 20546955
[TBL] [Abstract][Full Text] [Related]
4. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases.
Magna M; Pisetsky DS
Mol Med; 2014 Mar; 20(1):138-46. PubMed ID: 24531836
[TBL] [Abstract][Full Text] [Related]
5. The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus.
Yu SL; Wong CK; Tam LS
Expert Rev Clin Immunol; 2013 Aug; 9(8):739-49. PubMed ID: 23971752
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.
Schaper F; Westra J; Bijl M
Mol Med; 2014 Mar; 20(1):72-9. PubMed ID: 24531837
[TBL] [Abstract][Full Text] [Related]
7. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
8. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.
Urbonaviciute V; Voll RE
J Intern Med; 2011 Oct; 270(4):309-18. PubMed ID: 21793951
[TBL] [Abstract][Full Text] [Related]
9. Redox modifications of cysteine residues regulate the cytokine activity of HMGB1.
Yang H; Lundbäck P; Ottosson L; Erlandsson-Harris H; Venereau E; Bianchi ME; Al-Abed Y; Andersson U; Tracey KJ
Mol Med; 2021 Jun; 27(1):58. PubMed ID: 34098868
[TBL] [Abstract][Full Text] [Related]
10. The translocation of HMGB1 during cell activation and cell death.
Gauley J; Pisetsky DS
Autoimmunity; 2009 May; 42(4):299-301. PubMed ID: 19811282
[TBL] [Abstract][Full Text] [Related]
11. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).
Yang H; Lundbäck P; Ottosson L; Erlandsson-Harris H; Venereau E; Bianchi ME; Al-Abed Y; Andersson U; Tracey KJ; Antoine DJ
Mol Med; 2012 Mar; 18(1):250-9. PubMed ID: 22105604
[TBL] [Abstract][Full Text] [Related]
12. The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer.
Diener KR; Al-Dasooqi N; Lousberg EL; Hayball JD
Immunol Cell Biol; 2013 Aug; 91(7):443-50. PubMed ID: 23797067
[TBL] [Abstract][Full Text] [Related]
13. The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens.
Willis WL; Wang L; Wada TT; Gardner M; Abdouni O; Hampton J; Valiente G; Young N; Ardoin S; Agarwal S; Freitas MA; Wu LC; Jarjour WN
J Biol Chem; 2018 Jun; 293(22):8394-8409. PubMed ID: 29618516
[TBL] [Abstract][Full Text] [Related]
14. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.
Harris HE; Andersson U; Pisetsky DS
Nat Rev Rheumatol; 2012 Jan; 8(4):195-202. PubMed ID: 22293756
[TBL] [Abstract][Full Text] [Related]
15. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).
Ge X; Antoine DJ; Lu Y; Arriazu E; Leung TM; Klepper AL; Branch AD; Fiel MI; Nieto N
J Biol Chem; 2014 Aug; 289(33):22672-22691. PubMed ID: 24928512
[TBL] [Abstract][Full Text] [Related]
16. High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus.
Pan HF; Wu GC; Li WP; Li XP; Ye DQ
Mol Biol Rep; 2010 Mar; 37(3):1191-5. PubMed ID: 19247800
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1, oxidative stress, and disease.
Tang D; Kang R; Zeh HJ; Lotze MT
Antioxid Redox Signal; 2011 Apr; 14(7):1315-35. PubMed ID: 20969478
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
19. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis.
Yang H; Antoine DJ; Andersson U; Tracey KJ
J Leukoc Biol; 2013 Jun; 93(6):865-73. PubMed ID: 23446148
[TBL] [Abstract][Full Text] [Related]
20. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells.
Lotfi R; Herzog GI; DeMarco RA; Beer-Stolz D; Lee JJ; Rubartelli A; Schrezenmeier H; Lotze MT
J Immunol; 2009 Oct; 183(8):5023-31. PubMed ID: 19794066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
